Search Results

Recent Research from University of North Carolina Highlight Findings in Fibrinolysis (Clot Formation and Fibrinolysis Assays Reveal Functional Differences Among Hemostatic Agents In Hemophilia a Plasma).

Subjects: FIBRINOLYSIS; HEMOPHILIA; UNIVERSITY research

• Source: Drug Week; 5/24/2024, p1535-1535, 1p

Record details

Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?

• Authors : Antovic, J. P.; Schulman, S.; An, S. S. A.

Subjects: FIBRINOLYSIS; CARBOXYPEPTIDASES; PEPTIDASE

• Source: Scandinavian Journal of Clinical & Laboratory Investigation. Dec2004, Vol. 64 Issue 8, p745-751. 7p.

Record details

Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.

• Authors : FOLEY, J. H.¹; NESHEIM, M. E.^2,3; RIVARD, G. E.⁴

Subjects: *THROMBIN; *FIBRINOLYSIS; *HEMOPHILIA

• Source: Haemophilia. May2012, Vol. 18 Issue 3, pe316-e322. 7p. 2 Charts, 2 Graphs.

Record details

On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients.

• Authors : MIKOVIC, D.; WOODHAMS, B. J.; HOLMSTRÖM, M.

Subjects: ANTIFIBRINOLYTIC agents; BLOOD coagulation factors; COMPARATIVE studies

• Source: International Journal of Laboratory Hematology. Feb2012, Vol. 34 Issue 1, p35-40. 6p. 1 Graph.

Record details

New Blood Coagulation and Fibrinolysis Study Findings Have Been Reported by Researchers at Dr. Ram Manohar Lohia Institute of Medical Sciences (Mixing-based Inhibitor Screening In Haemophilia A: Challenges In Interpretation)

• Source: Obesity, Fitness & Wellness Week. February 8, 2020, 2202

Record details

Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia.

• Authors : Grünewald, M.¹; Siegemund, A.²; Grünewald, A.¹

Subjects: *HEMOPHILIA; *FIBRINOLYSIS; *JOINT diseases

• Source: Haemophilia. Nov2002, Vol. 8 Issue 6, p768-775. 8p.

Record details

Use of global assays to understand clinical phenotype in congenital factor VII deficiency.

• Authors : Greene, L. A.; Goldenberg, N. A.; Simpson, M. L.

Subjects: HEMORRHAGE prevention; HEMOPHILIA; BLOOD coagulation

• Source: Haemophilia. Sep2013, Vol. 19 Issue 5, p765-772. 8p. 2 Charts, 2 Graphs.

Record details

Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters.

• Authors : Tuinenburg, A.; Biere‐Rafi, S.; Peters, M.

Subjects: OBESITY; HEMOPHILIA; HEMOPHILIACS

• Source: Haemophilia. Sep2013, Vol. 19 Issue 5, p744-752. 9p. 4 Charts, 1 Graph.

Record details

The influence of isotretinoin upon fibrinolysis in patients with acne.

• Authors : Dootson, G. M.; Keidan, J.; Harper, P. L.

Subjects: ISOTRETINOIN; FIBRINOLYSIS; ACNE

• Source: British Journal of Dermatology; Jul1995, Vol. 133 Issue 1, p66-70, 5p

Record details

Research on Fibrinolysis Discussed by Investigators at Dokuz Eylul University

• Source: Obesity, Fitness & Wellness Week. February 11, 2012, 2222

Record details